Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease
Inflammatory Bowel Diseases · 01.02.2023 · 29 (2) · 274-285
DOI: 10.1093/ibd/izac201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 07.10.2022. Verfasst von Sushma Chowdary Maddipatla und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Department of Pediatrics and Pediatric Research Institute, Children's Healthcare of Atlanta, Emory University…. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, Leona M. and Harry B. Helmsley Charitable Trust.
Abstract (Originalsprache)
Background
Crohn’s disease is a lifelong disease characterized by chronic inflammation of the gastrointestinal tract. Defining the cellular and transcriptional composition of the mucosa at different stages of disease progression is needed for personalized therapy in Crohn’s.
Methods
Ileal biopsies were obtained from (1) control subjects (n = 6), (2) treatment-naïve patients (n = 7), and (3) established (n = 14) Crohn’s patients along with remission (n = 3) and refractory (n = 11) treatment groups. The biopsies processed using 10x Genomics single cell 5' yielded 139 906 cells. Gene expression count matrices of all samples were analyzed by reciprocal principal component integration, followed by clustering analysis. Manual annotations of the clusters were performed using canonical gene markers. Cell type proportions, differential expression analysis, and gene ontology enrichment were carried out for each cell type.
Results
We identified 3 cellular compartments with 9 epithelial, 1 stromal, and 5 immune cell subtypes. We observed differences in the cellular composition between control, treatment-naïve, and established groups, with the significant changes in the epithelial subtypes of the treatment-naïve patients, including microfold, tuft, goblet, enterocyte,s and BEST4+ cells. Surprisingly, fewer changes in the composition of the immune compartment were observed; however, gene expression in the epithelial and immune compartment was different between Crohn’s phenotypes, indicating changes in cellular activity.
Conclusions
Our study identified cellular and transcriptional signatures associated with treatment-naïve Crohn’s disease that collectively point to dysfunction of the intestinal barrier with an increase in inflammatory cellular activity. Our analysis also highlights the heterogeneity among patients within the same disease phenotype, shining a new light on personalized treatment responses and strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Department of Pediatrics and Pediatric Research Institute, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Pathology, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
- School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
- Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
- School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
- Lowance Center for Human Immunology, Division of Immunology and Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
ORCID-Profile: Subra Kugathasan
Förderung
- NIH HHS
- NIDDK NIH HHS
- Leona M. and Harry B. Helmsley Charitable Trust
- National Science Foundation
Zitieren
APA
Maddipatla, S. C., Kolachala, V. L., Venkateswaran, S., Dodd, A. F., Pelia, R. S., Geem, D., Yin, H., Sun, Y., Xu, C., Mo, A., Kosters, A., Yang, J., Matthews, J. D., Ghosn, E., Kugathasan, S., & Qiu, P. (2023). Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease. Inflammatory Bowel Diseases, 29(2), 274-285. https://doi.org/10.1093/ibd/izac201
Vancouver
Maddipatla SC, Kolachala VL, Venkateswaran S, Dodd AF, Pelia RS, Geem D, et al. Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease. Inflammatory Bowel Diseases. 2023;29(2):274-285. doi:10.1093/ibd/izac201
BibTeX
@article{Maddipatla2023,
author = {Maddipatla, Sushma Chowdary and Kolachala, Vasantha L and Venkateswaran, Suresh and Dodd, Anne F and Pelia, Ranjit Singh and Geem, Duke and Yin, Hong and Sun, Yutong and Xu, Congmin and Mo, Angela and Kosters, Astrid and Yang, Junkai and Matthews, Jason D and Ghosn, Eliver and Kugathasan, Subra and Qiu, Peng},
title = {Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease},
journal = {Inflammatory Bowel Diseases},
year = {2023},
volume = {29},
number = {2},
pages = {274--285},
doi = {10.1093/ibd/izac201}
}
EUVIMED